P

Inventor

WILLIAMS HAYDN W R

26 patents
⚠️ This page may combine multiple inventors who share the name “WILLIAMS HAYDN W R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

MERCK & CO INC

21 patents
US4432992AFeb 21, 1984

4-[5(and 4)-Substituted-2-thienyl]-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

MERCK & CO INC104 citations96
US4342776AAug 3, 1982

4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

MERCK & CO INC57 citations96
US4537902AAug 27, 1985

4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

MERCK & CO INC33 citations93
US4431652AFeb 14, 1984

4-Hydroxy-5-substituted-3(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis

MERCK & CO INC34 citations93
US4431660AFeb 14, 1984

(4'-Biphenylyloxy and-thio-oxy)-3-hydroxy-3-pyrroline-2,5-diones and a method of treating calcium oxalate renal lithiasis therewith

MERCK & CO INC35 citations93
US4428956AJan 31, 1984

4-Hydroxy-5-substituted-3-(2H)-isothiazolone-1,1-dioxide derivatives useful in treating urinary tract calcium oxalate lithiasis

MERCK & CO INC42 citations93
US4379791AApr 12, 1983

4-(Substituted thiazolyl)-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

MERCK & CO INC35 citations93
US4337258AJun 29, 1982

2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis

MERCK & CO INC32 citations93
US4336397AJun 22, 1982

2,4-Dioxo-4-substituted-1-butanoic acid derivatives useful in treating urinary tract calcium oxalate lithiasis

MERCK & CO INC42 citations93
US4298743ANov 3, 1981

4-(Substituted phenyl thiazolyl)-3-hydroxy-3-pyrroline-2,5-diones

MERCK & CO INC49 citations93
US4256758AMar 17, 1981

4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

MERCK & CO INC38 citations93
US4249021AFeb 3, 1981

Indanacetic acid compounds

MERCK & CO INC35 citations93
US4448786AMay 15, 1984

4-Naphthyl and substituted naphthyl-3-hydroxy-3-pyrroline-2,5-diones and their use as inhibitors of glycolic acid oxidase

MERCK & CO INC26 citations82
US4349561ASep 14, 1982

4-Substituted-3-hydroxy-3-pyrroline-2,5-dione inhibitors of glycolic acid oxidase

MERCK & CO INC24 citations82
US4233452ANov 11, 1980

Derivatives of glycolic and glyoxylic acid as inhibitors of glycolic acid oxidase

MERCK & CO INC28 citations82
US4207329AJun 10, 1980

Derivatives of glycolic and glyoxylic acid as inhibitors of glycolic acid oxidase

MERCK & CO INC26 citations82
US4178386ADec 11, 1979

Inhibitors of glycolic acid oxidase

MERCK & CO INC22 citations82
US4423063ADec 27, 1983

2,4-Dioxo-4-substituted-1-butaoic acid derivatives useful in treating urinary track calcium oxalate lithiasis

MERCK & CO INC14 citations72
US4424355AJan 3, 1984

Resolution of substituted dibenzo b,f!thiepin-3-carboxylic acid-5-oxides with brucine or ephedrine

MERCK & CO INC3 citations63
US3944560AMar 16, 1976

3-Hydroxy-3-(1,2,5-thiadiazolyloxyalkanol)-3,4-dihydro-2H-1,5-benzodioxepin products

MERCK & CO INC5 citations60
US4435579AMar 6, 1984

Resolution of substituted dibenzo[b,f]thiepin-3-carboxylic acid-5-oxides with ephedrine

MERCK & CO INC1 citations52

MERCK FROSST CANADA INC

4 patents

MERCK SHARP & DOHME

1 patent